What one share of Rani Therapeutics Holdings holds
We are a clinical stage biotherapeutics company focusing on advancing technologies to enable the administration of biologics and drugs orally, to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections.
Rani Therapeutics Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.04 |
|---|---|
| Profit | −$0.22 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.15 |
| Cash and investments | $0.03 |
| Debt | $0.00 |
| Book value | $0.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | $0.14 | −$0.43 | $0.03 | −$1.68 | — | $2.43 |
| 2022 | $0.00 | −$1.28 | $0.07 | −$2.02 | — | $1.55 |
| 2023 | $0.00 | −$1.33 | $0.05 | −$2.06 | — | $0.50 |
| 2024 | $0.04 | −$1.05 | $0.01 | −$1.26 | — | $0.07 |
| 2025 | $0.02 | −$0.45 | $0.00 | −$0.28 | — | $0.50 |
Common questions about Rani Therapeutics Holdings
How much does one share of Rani Therapeutics Holdings earn?
Over the last 12 months, Rani Therapeutics Holdings lost $0.22 for each share on $0.04 of sales.
Does Rani Therapeutics Holdings pay a dividend?
Rani Therapeutics Holdings didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Rani Therapeutics Holdings’s book value per share?
Rani Therapeutics Holdings’s book value is $0.21 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Rani Therapeutics Holdings have?
Each share of Rani Therapeutics Holdings has $0.03 of cash and investments and $0.00 of debt, as of June 30, 2026.
What is Rani Therapeutics Holdings’s free cash flow per share?
−$0.15 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Rani Therapeutics Holdings bought back shares?
Rani Therapeutics Holdings’s share count rose about 239% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.